BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12153803)

  • 1. Successful treatment of serpiginous choroiditis with alkylating agents.
    Akpek EK; Jabs DA; Tessler HH; Joondeph BC; Foster CS
    Ophthalmology; 2002 Aug; 109(8):1506-13. PubMed ID: 12153803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Serpiginous Choroiditis with Chlorambucil: A Report of 17 Patients.
    Ebrahimiadib N; Modjtahedi BS; Davoudi S; Foster CS
    Ocul Immunol Inflamm; 2018; 26(2):228-238. PubMed ID: 27754769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serpiginous Choroiditis.
    Ahmed AH; Kubaisi B; Foster CS
    JAMA Ophthalmol; 2017 Apr; 135(4):e165495. PubMed ID: 28418567
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon alpha-2a treatment for serpiginous choroiditis.
    Sobaci G; Bayraktar Z; Bayer A
    Ocul Immunol Inflamm; 2005 Feb; 13(1):59-66. PubMed ID: 15804771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term immunosuppressive treatment of serpiginous choroiditis.
    Akpek EK; Baltatzis S; Yang J; Foster CS
    Ocul Immunol Inflamm; 2001 Sep; 9(3):153-67. PubMed ID: 11815884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of azathioprine and corticosteroids in the treatment of serpiginous choroiditis.
    Vianna RN; Ozdal PC; Deschênes J; Burnier MN
    Can J Ophthalmol; 2006 Apr; 41(2):183-9. PubMed ID: 16767205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical profile, treatment, and visual outcome of serpiginous choroiditis.
    Abrez H; Biswas J; Sudharshan S
    Ocul Immunol Inflamm; 2007; 15(4):325-35. PubMed ID: 17763131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive therapy in serpiginous choroiditis--case report and brief review of the literature.
    Vonmoos F; Messerli J; Moser HR; Prünte C; Flammer J; Haefliger IO
    Klin Monbl Augenheilkd; 2001 May; 218(5):394-7. PubMed ID: 11417346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubercular serpiginous-like choroiditis presenting as multifocal serpiginoid choroiditis.
    Bansal R; Gupta A; Gupta V; Dogra MR; Sharma A; Bambery P
    Ophthalmology; 2012 Nov; 119(11):2334-42. PubMed ID: 22892153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of patients with serpinginous choroiditis.
    Christmas NJ; Oh KT; Oh DM; Folk JC
    Retina; 2002 Oct; 22(5):550-6. PubMed ID: 12441719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulse cyclophosphamide therapy in the management of patients with macular serpiginous choroidopathy.
    Venkatesh P; Gogia V; Gupta S; Tayade A; Shilpy N; Shah BM; Guleria R
    Indian J Ophthalmol; 2015 Apr; 63(4):318-22. PubMed ID: 26044470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of chlorambucil in intractable noninfectious uveitis: the Massachusetts Eye and Ear Infirmary experience.
    Miserocchi E; Baltatzis S; Ekong A; Roque M; Foster CS
    Ophthalmology; 2002 Jan; 109(1):137-42. PubMed ID: 11772593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical profile, treatment, and visual outcome of ampiginous choroiditis.
    Jyotirmay B; Jafferji SS; Sudharshan S; Kalpana B
    Ocul Immunol Inflamm; 2010 Jan; 18(1):46-51. PubMed ID: 20128650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal methotrexate in the management of presumed tuberculous serpiginous-like choroiditis.
    Julian K; Langner-Wegscheider BJ; Haas A; De Smet MD
    Retina; 2013 Oct; 33(9):1943-8. PubMed ID: 23584698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular serpiginous choroiditis.
    Sahu DK; Rawoof A; Sujatha B
    Indian J Ophthalmol; 2002 Sep; 50(3):189-96. PubMed ID: 12355692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis.
    Ghose A; Bhende PS; Biswas J
    Indian J Ophthalmol; 2016 Sep; 64(9):681-682. PubMed ID: 27853021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term Intensive Immunosuppression: A Randomized, Three-arm Study of Intravenous Pulse Methylprednisolone and Cyclophosphamide in Macular Serpiginous Choroiditis.
    Venkatesh P; Tayade A; Gogia V; Gupta S; Shah BM; Vohra R
    Ocul Immunol Inflamm; 2018; 26(3):469-476. PubMed ID: 27849419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifocal choroiditis and panuveitis: immunomodulatory therapy.
    Michel SS; Ekong A; Baltatzis S; Foster CS
    Ophthalmology; 2002 Feb; 109(2):378-83. PubMed ID: 11825826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of the natural history and management of serpiginous choroiditis in Australia and New Zealand.
    Toniolo J; Hall AJ; Sims J; Fraser-Bell S; Khan J; Younan C; Kent-Smith B; Young S; Paul E; Lim LL
    Clin Exp Ophthalmol; 2014; 42(7):656-64. PubMed ID: 24330142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple agent immunosuppression in serpiginous choroiditis.
    Hooper PL; Kaplan HJ
    Ophthalmology; 1991 Jun; 98(6):944-51; discussion 951-2. PubMed ID: 1866149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.